chr11-72822237-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033388.2(ATG16L2):āc.586G>Cā(p.Val196Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000702 in 1,495,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L2 | NM_033388.2 | c.586G>C | p.Val196Leu | missense_variant | 5/18 | ENST00000321297.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L2 | ENST00000321297.10 | c.586G>C | p.Val196Leu | missense_variant | 5/18 | 1 | NM_033388.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000362 AC: 55AN: 151954Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000885 AC: 8AN: 90386Hom.: 0 AF XY: 0.0000795 AC XY: 4AN XY: 50304
GnomAD4 exome AF: 0.0000372 AC: 50AN: 1342946Hom.: 0 Cov.: 33 AF XY: 0.0000318 AC XY: 21AN XY: 661358
GnomAD4 genome AF: 0.000362 AC: 55AN: 152058Hom.: 0 Cov.: 33 AF XY: 0.000404 AC XY: 30AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.586G>C (p.V196L) alteration is located in exon 5 (coding exon 5) of the ATG16L2 gene. This alteration results from a G to C substitution at nucleotide position 586, causing the valine (V) at amino acid position 196 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at